Arena Pharmaceuticals Inc Price/Sales
Cos'è Price/Sales di Arena Pharmaceuticals Inc?
Price/Sales di Arena Pharmaceuticals Inc è 112,536.89
Qual è la definizione di Price/Sales?
Il rapporto prezzo / vendite è il prezzo delle azioni di una società rispetto ai suoi ricavi.
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Price/Sales di aziende nel Health Care settore su NASDAQ rispetto a Arena Pharmaceuticals Inc
Cosa fa Arena Pharmaceuticals Inc?
Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas
Aziende con price/sales simili a Arena Pharmaceuticals Inc
- Sphinx Resources ha Price/Sales di 67,525.38
- BELLUS Health ha Price/Sales di 84,667.69
- Altius Renewable Royalties ha Price/Sales di 86,180.13
- Andhra Cements ha Price/Sales di 87,119.67
- Tamboran Resources Ltd ha Price/Sales di 99,124.18
- Magnetic Resources NL ha Price/Sales di 112,397.36
- Arena Pharmaceuticals Inc ha Price/Sales di 112,536.89
- Aurcana ha Price/Sales di 127,420.23
- HFX ha Price/Sales di 129,126.97
- Jindal Photo ha Price/Sales di 150,074.98
- Talon Metals ha Price/Sales di 157,309.73
- Nimy Resources Ltd ha Price/Sales di 174,464.42
- Grand Fortune High Grade ha Price/Sales di 184,615.38